An interventional study of disease self-management application in Non-small Cell Lung Cancer, sponsored by Chang Gung Memorial Hospital. Status unknown. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2022-11-10.
Sponsored by Chang Gung Memorial Hospital · Not applicable, Interventional, and Health services research
The study's purpose is to understand the self-management needs of patients with NSCLC receiving targeted therapy, develop a disease self- management application (mHealth Application), and explore the effect of mHealth application on the self-efficacy and health status of patients receiving targeted therapy for NSCLC.
This study adopts a two-group (pre-and-post-test) design experiment. This study is being conducted over a period of 3 years and is divided in two stages. This study enrolled patients with NSCLC in the outpatient clinic and ward of the Division of Chest Medicine in a northern medical center as the research participants. Stage 1 develop a disease self-management application and understands participants' needs by qualitative study. The participants are a purposive sample of 15-20 patients. Data discontinued when theme saturation is achieved. Stage 2 adopted convenient sampling to enroll 108 patients (54 in the experimental group and 54 in the control group) to evaluate the effectiveness of the disease self-management application. After participant's consent was obtained, this study performed the pre-test and randomized the participants. The experimental group received both routine care and the disease self-management App, while the control group received routine care and part of application. This study collected data before the patients received targeted therapy and in months 1, 3, 6, and 9 after treatment initiation.
7,243 studies on the registry are indexed under Lung Neoplasms; 1,557 are open to participants now.
This study's planned enrollment of 108 is above the median of 60 across 5,295 interventional studies indexed under Lung Neoplasms.
Browse Lung Neoplasms studies →Chang Gung Memorial Hospital is the lead sponsor of 1,064 studies on the registry; 235 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Other: disease self-management application
Other: disease self-management application
The mHealth application provide disease self-management knowledge and skills and also has the functions of level of skin toxicity warning, uploading photos of skin toxicity, and interacting with healthcare professionals.
European Organization for Research and Treatment of Cancer 30-item core quality of life questionnaire
assessing participants' quality of life
Time frame: change from baseline at 1 month
European Organization for Research and Treatment of Cancer 30-item core quality of life questionnaire
assessing participants' quality of life
Time frame: change from baseline at 3 month
European Organization for Research and Treatment of Cancer 30-item core quality of life questionnaire
assessing participants' quality of life
Time frame: change from baseline at 6 month
European Organization for Research and Treatment of Cancer 30-item core quality of life questionnaire
assessing participants' quality of life
Time frame: change from baseline at 9 month
NCI-CTCAE (ver 5.0) guideline
assessing participants' skin toxicity grade
Time frame: change from baseline at 1 month
NCI-CTCAE (ver 5.0) guideline
assessing participants' skin toxicity grade
Time frame: change from baseline at 3 month
NCI-CTCAE (ver 5.0) guideline
assessing participants' skin toxicity grade
Time frame: change from baseline at 6 month
NCI-CTCAE (ver 5.0) guideline
assessing participants' skin toxicity grade
Time frame: change from baseline at 9 month
knowledge and skills with disease self-management questionnaire
assessing participants' knowledge and skill ability with disease self-management
Time frame: change from baseline at 1 month
knowledge and skills with disease self-management questionnaire
assessing participants' knowledge and skill ability with disease self-management
Time frame: change from baseline at 3 month
knowledge and skills with disease self-management questionnaire
assessing participants' knowledge and skill ability with disease self-management
Time frame: change from baseline at 6 month
knowledge and skills with disease self-management questionnaire
assessing participants' knowledge and skill ability with disease self-management
Time frame: change from baseline at 9 month
disease self-efficacy questionnaire
assessing participants' self-efficacy with disease self-management
Time frame: change from baseline at 1 month
disease self-efficacy questionnaire
assessing participants' self-efficacy with disease self-management
Time frame: change from baseline at 3 month
disease self-efficacy questionnaire
assessing participants' self-efficacy with disease self-management
Time frame: change from baseline at 6 month
disease self-efficacy questionnaire
assessing participants' self-efficacy with disease self-management
Time frame: change from baseline at 9 month
Hospital Anxiety and Depression Scale
assessing participants' anxiety and depression
Time frame: change from baseline at 1 month
Hospital Anxiety and Depression Scale
assessing participants' anxiety and depression
Time frame: change from baseline at 3 month
Hospital Anxiety and Depression Scale
assessing participants' anxiety and depression
Time frame: change from baseline at 6 month
Hospital Anxiety and Depression Scale
assessing participants' anxiety and depression
Time frame: change from baseline at 9 month
Medical Outcomes Study-Social Support Survey
assessing participants' social support
Time frame: chang from baseline at 1 month
Medical Outcomes Study-Social Support Survey
assessing participants' social support
Time frame: chang from baseline at 3 month
Medical Outcomes Study-Social Support Survey
assessing participants' social support
Time frame: chang from baseline at 6 month
Medical Outcomes Study-Social Support Survey
assessing participants' social support
Time frame: chang from baseline at 9 month
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chang Gung Memorial Hospital